Uveitis Completed Phase 1 Trials for Efalizumab (DB00095)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00280826Efalizumab to Treat UveitisTreatment